To: J. Hoffstedt et al. (2002) The common -675 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity
The authors suggest that such further studies should preferably be based on population cohorts or on families. We studied 532 subjects recruited from 89 healthy families in a community-based cohort, the characteristics and analysis of which have been published earlier [2] .
Although there was a trend to higher BMI values in the 4G/4G genotype (mean values 26.3 kg/m 2 , 4G/4G; 25.9, 4G/5G: 25.4 5G/5G), this was not significant either in the population as a whole (p=0.29), or when analysed by sex. When the cohort was divided into groups according to WHO definitions: lean (BMI<25 kg/m 2 ), overweight (BMI 25-30 kg/m 2 ) and obese (BMI>30 kg/m 2 ), there was no difference in genotype frequency between the groups (Table 1) . Adjusted for age and sex, the heritability of BMI in these healthy families was 37% (95%CI 19-55). Evaluating contributors to variance of BMI shows problems due to the nature of the clustering in the insulin resistance syndrome where the distinction between cause and effect is often difficult to establish. However, 8% of BMI variance could be explained by epidemiological factors including age, sex, smoking habits and alcohol consumption. The PAI-1 4G/5G genotype was not a significant contributor to BMI variance (p=0.43) and was only a very minor contributor to the variance of PAI-1 (2%, p=0.001) in this population of healthy families [2] . Whilst the PAI-1 gene 4G/5G polymorphism has been shown to have a weak influence on PAI-1 levels [3] and PAI-1 levels are related to features of insulin resistance [4] , there is little evidence to suggest that the PAI-1 4G/5G genotype has a strong 
